These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1380242)

  • 21. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
    Andersson J; Nagy S; Groth CG; Andersson U
    Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
    Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
    J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: implications for mechanisms of IL-2-signal transduction.
    Taichman RS; Torigoe T; Tanaka S; Miyashita T; Reed JC
    Cytokine; 1992 Nov; 4(6):441-53. PubMed ID: 1292628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.
    Kobayashi N; Kono T; Hatakeyama M; Minami Y; Miyazaki T; Perlmutter RM; Taniguchi T
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4201-5. PubMed ID: 8483935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Ras in T lymphocyte activation.
    Ma P; Magut M; Faller DV; Chen CY
    Cell Signal; 2002 Oct; 14(10):849-59. PubMed ID: 12135706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis.
    Cristillo AD; Bierer BE
    J Biol Chem; 2002 Feb; 277(6):4465-76. PubMed ID: 11694517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a.
    Rudloff I; Bachmann M; Pfeilschifter J; Mühl H
    J Biol Chem; 2012 Feb; 287(7):4531-43. PubMed ID: 22170067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 4 inhibits IL-2-induced proliferation of a human T-leukemia cell line without interfering with p56-LCK kinase activation.
    Torigoe T; O'Connor R; Fagard R; Fischer S; Santoli D; Reed JC
    Cytokine; 1992 Sep; 4(5):369-76. PubMed ID: 1420998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
    Paliogianni F; Boumpas DT
    Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional mechanisms.
    Paillard F; Vaquero C
    Nucleic Acids Res; 1991 Sep; 19(17):4655-61. PubMed ID: 1832493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
    Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
    Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-2 does not overcome suppression of graft rejection by cyclosporin A: effect of cyclosporin A on T cell properties in vivo.
    Magae J; Matsubara H; Aotsuka N; Kurasawa K; Shearer GM
    Cell Immunol; 1996 Nov; 173(2):276-81. PubMed ID: 8912887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells.
    Murakami R; Kambe F; Mitsuyama H; Okumura K; Murohara T; Niwata S; Yamamoto R; Seo H
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2034-40. PubMed ID: 12958044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.
    Chen D; Rothenberg EV
    J Exp Med; 1994 Mar; 179(3):931-42. PubMed ID: 8113685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.
    Granelli-Piperno A; Nolan P; Inaba K; Steinman RM
    J Exp Med; 1990 Dec; 172(6):1869-72. PubMed ID: 1701825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.
    Evans GA; Howard OM; Erwin R; Farrar WL
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):339-42. PubMed ID: 7690544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.